Healthcare professionals generally agree that genetic testing can be useful in the HAE diagnostic process, but many urge caution in interpreting results.

Researchers have established clinical indications for pediatric blood transfusions with various ABO/Rh blood types that emphasize Rh compatibility.

Elevated basal serum tryptase levels in SM and HαT, as well as overlapping clinical characteristics, complicate the diagnostic process for both disorders.

Long-term prophylaxis with lanadelumab has been linked to a marked reduction in attack rates in HAE, with the decline persisting in a real-world setting.

Compound 23, a dual-target FGFR2/3 inhibitor, delivered superior growth improvements over infigratinib in achondroplasia mouse models.

There was high consensus among neurologists on treating acute attacks with high-dose steroids and plasmapheresis in severe cases. Rituximab is still the most prescribed treatment for neuromyelitis ...

Biomarkers are increasingly recognized for their use in diagnosing and tracking disability progression in NMOSD.

An elderly male patient presented with IgG4-related renal disease and was successfully treated with corticosteroids.

Researchers developed a new clinical score to estimate the probability of NMOSD in patients presenting with optic neuritis.

Patients with alpha-1 antitrypsin deficiency (AATD) and the PiZZ genotype have more aggressive disease than those with PiSZ.

In multivariable analysis, only del(11q)—not ATM mutation—was independently associated with high risk for early disease progression in CLL.

Two phase 3 clinical trials are recruiting patients with CIDP to evaluate the efficacy of riliprubart treatment.